These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 38404082)
1. Efficacy Of Levetiracetam Versus Phenytoin As A Second-Line Antiepileptic Drug In The Management Of Benzodiazepine-Refractory Status Epilepticus Among Children. Naeem B; Ashfaq M; Qureshi MA J Ayub Med Coll Abbottabad; 2023; 35(3):410-414. PubMed ID: 38404082 [TBL] [Abstract][Full Text] [Related]
2. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT. Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679 [TBL] [Abstract][Full Text] [Related]
3. A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study. Dalziel SR; Furyk J; Bonisch M; Oakley E; Borland M; Neutze J; Donath S; Sharpe C; Harvey S; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Sinn K; Kochar A; Brabyn C; Babl FE; BMC Pediatr; 2017 Jun; 17(1):152. PubMed ID: 28641582 [TBL] [Abstract][Full Text] [Related]
4. Levetiracetam versus phenytoin in management of status epilepticus. Chakravarthi S; Goyal MK; Modi M; Bhalla A; Singh P J Clin Neurosci; 2015 Jun; 22(6):959-63. PubMed ID: 25899652 [TBL] [Abstract][Full Text] [Related]
5. Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study. Gujjar AR; Nandhagopal R; Jacob PC; Al-Hashim A; Al-Amrani K; Ganguly SS; Al-Asmi A Seizure; 2017 Jul; 49():8-12. PubMed ID: 28528211 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Levetiracetam vs. Phenytoin as Second Line Antiseizure Medication for Pediatric Convulsive Status Epilepticus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Angurana SK; Suthar R J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34089322 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus. Nakamura K; Inokuchi R; Daidoji H; Naraba H; Sonoo T; Hashimoto H; Tokunaga K; Hiruma T; Doi K; Morimura N Medicine (Baltimore); 2017 Jun; 96(25):e7206. PubMed ID: 28640109 [TBL] [Abstract][Full Text] [Related]
8. Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis. DeMott JM; Slocum GW; Gottlieb M; Peksa GD Epilepsy Behav; 2020 Oct; 111():107286. PubMed ID: 32707535 [TBL] [Abstract][Full Text] [Related]
9. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial. Lyttle MD; Rainford NEA; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee ED; Potter S; Tate P; Iyer A; Evans V; Appleton RE; Lancet; 2019 May; 393(10186):2125-2134. PubMed ID: 31005385 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children. Besli GE; Yuksel Karatoprak E; Yilmaz S Epilepsy Behav; 2020 Oct; 111():107289. PubMed ID: 32702655 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children. Köle MT; Sager SG; Zeynel H; Çağ Y; Akın Y Childs Nerv Syst; 2022 Jul; 38(7):1357-1364. PubMed ID: 35501510 [TBL] [Abstract][Full Text] [Related]
12. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial. Dalziel SR; Borland ML; Furyk J; Bonisch M; Neutze J; Donath S; Francis KL; Sharpe C; Harvey AS; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Kochar A; Brabyn C; Oakley E; Babl FE; Lancet; 2019 May; 393(10186):2135-2145. PubMed ID: 31005386 [TBL] [Abstract][Full Text] [Related]
13. Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors. Swisher CB; Doreswamy M; Gingrich KJ; Vredenburgh JJ; Kolls BJ Neurocrit Care; 2012 Feb; 16(1):109-13. PubMed ID: 21882056 [TBL] [Abstract][Full Text] [Related]
14. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus. Kapur J; Elm J; Chamberlain JM; Barsan W; Cloyd J; Lowenstein D; Shinnar S; Conwit R; Meinzer C; Cock H; Fountain N; Connor JT; Silbergleit R; N Engl J Med; 2019 Nov; 381(22):2103-2113. PubMed ID: 31774955 [TBL] [Abstract][Full Text] [Related]
15. Levetiracetam versus Phenytoin for the Pharmacotherapy of Benzodiazepine-Refractory Status Epilepticus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Xue T; Wei L; Shen X; Wang Z; Chen Z; Wang Z CNS Drugs; 2020 Dec; 34(12):1205-1215. PubMed ID: 33111213 [TBL] [Abstract][Full Text] [Related]
16. Critical Care Management of Status Epilepticus at a Tertiary Care University Hospital. Mahmoud SH; Marette V; Lindqvist T; Ahmed SN Can J Neurol Sci; 2019 Nov; 46(6):702-710. PubMed ID: 31554529 [TBL] [Abstract][Full Text] [Related]
17. A comparison of four antiepileptic drugs in status epilepticus: experience from India. Misra UK; Kalita J Int J Neurosci; 2016 Nov; 126(11):1013-9. PubMed ID: 26456955 [TBL] [Abstract][Full Text] [Related]
18. Treatment of benzodiazepine-resistant status epilepticus: Systematic review and network meta-analyses. Jain P; Aneja S; Cunningham J; Arya R; Sharma S Seizure; 2022 Nov; 102():74-82. PubMed ID: 36209676 [TBL] [Abstract][Full Text] [Related]
19. Management of acute seizure and status epilepticus in pediatric emergency. Sasidaran K; Singhi S; Singhi P Indian J Pediatr; 2012 Apr; 79(4):510-7. PubMed ID: 22120613 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Chamberlain JM; Kapur J; Shinnar S; Elm J; Holsti M; Babcock L; Rogers A; Barsan W; Cloyd J; Lowenstein D; Bleck TP; Conwit R; Meinzer C; Cock H; Fountain NB; Underwood E; Connor JT; Silbergleit R; ; Lancet; 2020 Apr; 395(10231):1217-1224. PubMed ID: 32203691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]